Gerdtsson AS, Matos Rodrigues J, Eskelund CW, Husby S, et al. Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma
patients with poor response to standard high dose chemotherapy independent of
MIPI and complement established high-risk factors. Haematologica 2022 Dec 15. doi: 10.3324/haematol.2022.281420.
PMID: 36519324